Found 0 matching trials
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases PHASE1 This is an open, single-arm, clinical study to evaluate the efficacy and sa...
Show More Location
District One Hospital
Learn More & Join Trial
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults NA The purpose of the CliniMACS® TCRαβ-Biotin System and CliniMACS® CD19 is to...
Show More Location
Lucile Packard Children's Hospital
Learn More & Join Trial
Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 PHASE1 This study is an investigational approach that uses immune cells, called "T...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM PHASE1 This phase I trial studies the side effects and how well IL13Ralpha2-CAR T ...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies PHASE1 Phase 1/2 umbrella study evaluates biomarker-selected dual-target CAR-T cel...
Show More Location
Peking University Shenzhen Hospital
Learn More & Join Trial
4SCAR-T Therapy Post CD19-targeted Immunotherapy PHASE1 This study will evaluate safety and efficacy of a combination of 4th genera...
Show More Location
Shenzhen Geno-Immune Medical Institute
Learn More & Join Trial
The Safety and Efficacy of CART-19 Cells in B-cell Acute Lymphoblastic Leukemia (B-ALL). PHASE1 This is a study for patients who have been previously treated for B-ALL. Th...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies PHASE1 The purpose of this study is to test the safety of giving the patient speci...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Axi-Cel as a 2nd Line Therapy in Patients With Relapsed/Refractory Aggressive B Lymphoma Ineligible to Autologous Stem Cell Transplantation PHASE2 This is a phase 2, open-label, multicenter study evaluating axicabtagene ci...
Show More Status
Active Not Recruiting
Learn More & Join Trial
CD19/22 Bi-specific CAR-T Cell Therapy PHASE1 The purpose of this study is to assess the feasibility, safety and efficacy...
Show More Location
Shenzhen Geno-immune Medical Institute
Learn More & Join Trial